MedPath

Development, Validity, and Reliability of the Reactive Skill Test in Older Adults

Not Applicable
Completed
Conditions
Aging
Cognitive Performance
Registration Number
NCT07103837
Lead Sponsor
Balikesir University
Brief Summary

Aging is associated with cognitive and physical decline, leading to an increased risk of falls in older adults. Recent evidence highlights the critical role of cognitive functions-such as attention, memory, and executive functioning-in postural control and fall risk. This study aims to develop and validate a novel Reactive Skill Test (RST) that simultaneously assesses cognitive (reaction time, visual attention, short-term memory) and motor responses in older adults. The test involves matching colored stimuli to targets using a color-coded pod and cone setup controlled via the ReactionX system. The validity of RST will be examined through correlations with established cognitive and fall risk measures, while test-retest reliability will be assessed across separate sessions. This tool may provide early detection of cognitive-motor impairments contributing to fall risk in aging populations.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
25
Inclusion Criteria
  • Being over 60 years of age
  • Scoring at least 10 points on the Mini-Mental State Examination (MMSE)
  • Ability to ambulate independently
  • Being literate
  • Providing informed consent to participate in the study
Exclusion Criteria
  • Inability to ambulate independently
  • Scoring below 10 points on the Mini-Mental State Examination (MMSE)

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Development of the Reactive Skills TestFor the reliability of RBT, the test will be performed again one week later at the same time of day.

The Reactive Skill Test will be conducted using a setup consisting of four pods, white cones, and balls that match the colors of the light signals. During the test, a ReactionX device configured with four distinct light colors (red, green, blue, and yellow) will be used. The test protocol is programmed via the ReactionX mobile application to control the sequence and display of lights. Each LED light is illuminated in a randomized order with zero delay time. Upon illumination, the participant is required to select the ball corresponding to the color of the light, place it on the matching cone, and then deactivate the LED light of the same color as the last placed ball. The test concludes once this sequence is completed for all four lights. Performance is evaluated based on parameters such as reaction time, accuracy, and total completion time. This protocol is specifically designed to assess cognitive skills such as color recognition, reaction speed, motor coordination and attention.

Secondary Outcome Measures
NameTimeMethod
Mini-Mental State Examination (MMSE)the first day of inclusion in the study, once

The Mini-Mental State Examination (MMSE) is widely recognized as one of the most commonly used tools for assessing cognitive impairment worldwide. The MMSE evaluates orientation, memory, attention, calculation, recall, language, motor function, perception, and visuospatial abilities. Its ease and rapid administration are among its main advantages. In this study, the MMSE will be used to assess cognitive function. Scores ranging from 27 to 30 are considered normal, 24 to 27 indicate mild cognitive impairment, 20 to 23 represent mild dementia, 10 to 19 correspond to moderate dementia, and scores below 10 indicate severe dementia.

Five Times Sit-to-Stand Test (FTSST)the first day of inclusion in the study, once

The Five Times Sit-to-Stand Test is a standardized assessment used to evaluate lower extremity muscle strength and balance in older adults. Participants sit on a backless chair 45 cm in height with their arms crossed over their chest and are instructed to stand up and sit down five times as quickly as possible. Performance is measured by timing the duration from the initial seated position to the final seated position using a stopwatch. The validity of the test is supported by its correlation with measures of knee extension strength and walking performance. It assesses lower limb strength and functional mobility. Times exceeding 15 seconds are associated with a higher risk of falls. The test will be performed three times, and the average time will be recorded.

International Physical Activity Questionnaire (Short Form)the first day of inclusion in the study, once

This questionnaire will be used to assess participants' physical activity levels in daily life. Participants report the types of activities performed and the time spent on each over the past seven days. Walking, sitting, moderate-intensity, and vigorous-intensity activities will be recorded based on participant self-report. The score is calculated by multiplying the MET value assigned to each activity by the duration and the number of days performed per week, resulting in a MET-minutes/week value. MET values are assigned as follows: walking = 3.3 MET, moderate activity = 4 MET, and vigorous activity = 8 MET. Based on these scores, participants will be classified into three categories: physically inactive (\<600 MET-min/week), low physical activity level (600-1500 MET-min/week), and sufficient physical activity level (\>1500 MET-min/week).

Hand Reaction Time Testthe first day of inclusion in the study, once

Hand movement reaction times will be recorded using an LED light system connected to a smartphone application (ReactionX). The ReactionX system consists of six LEDs and a wireless lighting setup. Participants will be seated with both hands placed on the table, palms down, spaced 40 cm apart (ReactionX device positioned centrally, 20 cm from each hand) and elbows flexed at 90°. When a light illuminates, participants are instructed to touch the device with the indicated hand as quickly as possible to turn off the light. Each test will be performed six times, with the best trial recorded. Results will be expressed in milliseconds (ms).

Trial Locations

Locations (1)

Balikesir University

🇹🇷

Balıkesir, Bigadiç, Turkey

Balikesir University
🇹🇷Balıkesir, Bigadiç, Turkey

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.